Search for more clinical trials
Cancer Research Repository for Individuals With Cancer Diagnosis and High Risk Individuals.
Conditions
Pancreatic Cancer - Thyroid Cancer - Lung Cancer - Esophageal Cancer - Thymus Cancer - Colon Cancer - Rectal Cancer - GIST - Anal Cancer - Bile Duct Cancer - Duodenal Cancer - Gallbladder Cancer - Gastric Cancer - Liver Cancer - Small Intestine Cancer - Peritoneal Surface Malignancies - Familial Adenomatous Polyposis - Lynch Syndrome - Bladder Cancer - Kidney Cancer - Penile Cancer - Prostate Cancer - Testicular Cancer - Ureter Cancer - Urethral Cancer - Hypopharyngeal Cancer - Laryngeal Cancer - Lip Cancer - Oral Cavity Cancer - Nasopharyngeal Cancer - Oropharyngeal Cancer - Paranasal Sinus Cancer - Nasal Cavity Cancer - Salivary Gland Cancer - Skin Cancer - CNS Tumor - CNS Cancer - Mesothelioma
Conditions: official terms
Adenomatous Polyposis Coli - Cholangiocarcinoma - Duodenal Neoplasms - Esophageal Neoplasms - Hypopharyngeal Neoplasms - Mesothelioma - Mouth Neoplasms - Oropharyngeal Neoplasms - Pancreatic Neoplasms - Paranasal Sinus Neoplasms - Testicular Neoplasms - Thyroid Neoplasms
Conditions: Keywords
Pancreatic Cancer, Thyroid Cancer, Lung Cancer, Esophageal cancer, Thymus cancer, Pancreatic tumor, Esophageal tumor, Thymus tumor, Thyroid Tumor, Thyroid Nodule, Lung Tumor
Study Type
Observational [Patient Registry]
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Recruiting
Summary
The objectives of this project at UNMC are to consolidate existing and future disease specific registries with biospecimen bank to provide a resource that fosters and improves the efficiency of cancer-related research and facilitates collaborations among centers. The Integrated Cancer Repository for Cancer Research (iCaRe2) consists mainly of registry database and human biological material (HBM). The type of HBM to be stored include blood (and its derivatives), urine and tissue. The source of the HBM will be from voluntary blood draw, urine collection and UNMC Solid Tumor Bank (IRB#281-96).
Detailed Description
Currently, there are seven registries/tissue bank developed under the umbrella of iCaRe2: the Pancreatic Cancer Collaborative Registry (PCCR), Thyroid Cancer and Tumor Collaborative Registry (TCCR), GenitoUrinary Cancer Collaborative Registry (GUCaRe), Thoracic Oncology Collaborative Registry (TOCR), Gastrointestinal and Abdominal Cancer Collaborative Registry (GACCaRe), Head and Neck Cancer Collaborative Registry (HNCCR), Central Nervous System Tumor Collaborative Registry (CTCR) for collaborative multi-center research. These Cancer Registries (CR) were established to unite participating centers with expertise in cancer epidemiology, genetics, biology, early detection and patient care to facilitate the rapid and uniform collection of critical information and biological samples to be used in developing prevention, detection and treatment strategies against cancer. Fred and Pamela Buffett Cancer Center also adopted the caTISSUE Suite (https://cabig.nci.nih.gov/tools/catissuesuite), a biorepository tool that has been developed under the NCI's cancer Biomedical Informatics Grid (caBIG®) umbrella. The Cancer Registry (CR) database is coupled with the biospecimen annotation database (caTISSUE) to manage activities associated with the biospecimen inventorying, tracking, and basic annotation. It provides quality assurance for all these activities and permits the users to track the collection, storage and distribution (derivation and aliquot) of specimens. This consolidated tissue bank will continue to collect and store comprehensive data on cancer patients, survivors and high-risk individuals. The tissue bank couples with the caTissue Suite for annotation and management of the biospecimen data to be collected. Consolidating all the registries into one tissue bank will foster and improve the efficiency of cancer-related research and facilitates collaborations among centers. The PI from each registry will remain the sole contact and will maintain responsibility of the conduct of each registry. For the purpose of consolidation into one IRB application, each PI is being assigned as Sub-PI. Namely, PCCR - Dr.Aaron Sasson, TCCR - Dr. Whitney Goldner, GUCaRe - Dr. Chad LaGrange , TOCR - Dr.Karin Trujillo, GACCaRe- Dr. Jason Foster, HNCCR- Dr.
Russell Smith, CTCR- Dr. Nicole Shonka respectively.
Russell Smith, CTCR- Dr. Nicole Shonka respectively.
Criteria for eligibility
Healthy Volunteers: Accepts Healthy Volunteers
Maximum Age: N/A
Minimum Age: 19 Years
Gender: Both
Criteria: Inclusion Criteria:
1. All adults (male and female, age 19 and older) who have diagnosis of cancer;
2. All adults considered to be an "at risk individual for cancer", such as but not limited to a tumor, mass, nodules, family history of cancer, or suspicious clinical findings.
3. Able to provide informed consent.
4. English speaking.
Exclusion Criteria:
1. Individual younger than 19 years of age.
2. Individual who is unable to provide informed consent.
1. All adults (male and female, age 19 and older) who have diagnosis of cancer;
2. All adults considered to be an "at risk individual for cancer", such as but not limited to a tumor, mass, nodules, family history of cancer, or suspicious clinical findings.
3. Able to provide informed consent.
4. English speaking.
Exclusion Criteria:
1. Individual younger than 19 years of age.
2. Individual who is unable to provide informed consent.
Locations
University of Alabama Birmingham
Birmingham, Alabama, United States
NorthShore University Health System
Status: Recruiting
Contact: Charles Wilcox, MD
Evanston, Illinois, United States
Parkview Research Center
Status: Recruiting
Contact: Kristen Vogel, MS, CGC - 847-570-1322
Fort Wayne, Indiana, United States
University of Michigan Health System
Status: Recruiting
Contact: Neil Sharma, MD
Ann Arbor, Michigan, United States
University of Minnesota
Status: Recruiting
Contact: Michelle Anderson, MD - 734-936-4775
Minneapolis, Minnesota, United States
Methodist Estabrook Cancer Center
Status: Recruiting
Contact: Eric Jensen, MD
Omaha, Nebraska, United States
University of Nebraska Medical Center
Status: Recruiting
Contact: Russell Smith, MD
Omaha, Nebraska, United States
Memorial Sloan Kettering Cancer Center
Status: Recruiting
Contact: Whitney Goldner, MD - 402-559-3579
New York, New York, United States
University of Pittsburgh
Status: Recruiting
Contact: Peter Allen - 212-639-8714
Pittsburgh, Pennsylvania, United States
Avera Cancer Institute
Status: Recruiting
Contact: Randall Brand, MD - 412-623-4124
Sioux Falls, South Dakota, United States
Sanford Health
Status: Recruiting
Contact: Charles Longo, MD - 605-322-7600
Sioux Falls, South Dakota, United States
University of Genoa
Status: Recruiting
Contact: William Spanos, MD - 605-328-8200
Genoa, Italy
Status: Recruiting
Contact: Paola Ghiorzo, PhD - 390103538949
Start Date
November 2013
Completion Date
December 2099
Sponsors
University of Nebraska
Source
University of Nebraska
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page